US FDA Says To Stop Using 2 Eye Drop Products Because Of Serious Health Risks

Maryland : Federal health regulators are warning consumers to immediately stop using two additional eye drop products because of potential bacterial or fungal contamination.

The Food and Drug Administration is advising people not to buy “Dr. Berne’s MSM Drops 5% Solution” and “LightEyez MSM Eye Drops – Eye Repair,” warning that they could pose a serious health risk, including vision- and life-threatening infections. The agency noted that it doesn’t know of anyone who has reported a problem due to the products.

The latest recalls follow a spate of FDA warnings earlier this year against using several eye drop brands linked to an outbreak of drug-resistant bacteria. The outbreak is linked to at least 4 deaths across 18 states and dozens of infections.

Dr. Berne’s Whole Health Products distributes Dr. Berne’s products, while LightEyez Limited is the distributor of Light Eyez products.

The FDA’s testing of the products found they were contaminated with microbes and were not sterile, which is required under the Federal Food, Drug and Cosmetic Act. Both products, which the agency said are unapproved and are being illegally marketed in the U.S., also contain methylsulfonylmethane (MSM) as an active ingredient, which is not approved in eye drop products.

“Using contaminated eye drops could result in minor to serious vision-threatening infection which could possibly progress to a life-threatening infection,” the FDA said.

Dr. Berne issued a voluntary recall of the Dr. Berne’s MSM Drops 5% Solution, while London-based LightEyez Limited has not responded to the FDA nor taken actions to protect consumers, according to the agency.

According to the FDA, LightEyez’s product was contaminated with Pseudomonas aeruginosa, a bacteria that can cause infections in the blood, lungs or other parts of the body. Health authorities think a drug-resistant variant of the bacteria is responsible for the deaths and other health problems tied to suspect eye drops.

Global Pharma Healthcare in February recalled all lots of its EzriCare and Delsam Pharma brands of “Artificial Tears Lubricant Eye Drops,” which it said could be contaminated with bacteria.

Related Posts

  • Pharma
  • June 17, 2025
  • 93 views
Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…

  • Pharma
  • June 17, 2025
  • 98 views
Zydus Healthcare appoints Swati Dalal MD

Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director and Managing Director of its wholly-owned arm Zydus Healthcare Ltd. The board of Zydus Healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco API plant gets one observation from FDA

Natco API plant gets one observation from FDA